Overdiagnosis across medical disciplines: A scoping review

BMJ Open

Volumn 7, Issue 12, 2017, Pages

  Jenniskens, Kevin ^a   De Groot, Joris A H ^a   Reitsma, Johannes B ^a   Moons, Karel G M ^a   Hooft, Lotty ^a   Naaktgeboren, Christiana A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CARDIOVASCULAR DISEASE; DIAGNOSIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; GENOMICS; HUMAN; INCIDENTAL FINDING; INFECTION; INTERPERSONAL COMMUNICATION; MALIGNANT NEOPLASM; MEDICAL RESEARCH; MENTAL DISEASE; METHODOLOGY; OVERDIAGNOSIS; REVIEW; SCREENING; SYSTEMATIC REVIEW; CARDIOLOGY; HEALTH SERVICE; INFECTIOUS DISEASE MEDICINE; ONCOLOGY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UTILIZATION;

CARDIOLOGY; DIAGNOSTIC TESTS, ROUTINE; HUMANS; INFECTIOUS DISEASE MEDICINE; MEDICAL ONCOLOGY; MEDICAL OVERUSE; PSYCHOLOGY;

EID: 85042108333     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-018448     Document Type: Review

References (69)

1. Carter SM, Rogers W, Heath I, et al. The challenge of overdiagnosis begins with its definition. BMJ 2015;350:h869.
2. ABIM foundation. Choosing wisely around the world. 2015. http://www. choosingwisely. org/resources/updates-from-the-field/choosingwisely-around-the-world/(accessed 4 Jan 2017).
3. Otte JA. Less is more medicine. http://www. lessismoremedicine. com/projects/(accessed 9 May 2017).
4. Welch GH. Overdiagnosed: Making People Sick in the Pursuit of Health, 2010.
5. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000;92:1280-2.
6. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502.
7. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-13.
8. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90.
9. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6.
10. Preventing Overdiagnosis. Preventing overdiagnosis conference. http ://www. preventingove rdia gnos is. net/(accessed 4 Jan 2014).
11. Bae JM. Overdiagnosis: epidemiologic concepts and estimation. Epidemiol Health 2015;37:e2015004.
12. Bach PB. Overdiagnosis in lung cancer: different perspectives, definitions, implications. Thorax 2008;63:298-300.
13. Rogers WA, Mintzker Y. Getting clearer on overdiagnosis. J Eval Clin Pract 2016;22:580-7.
14. Hofmann BM. Conceptual overdiagnosis. a comment on wendy rogers and yishai mintzker's article "getting clearer on overdiagnosis". J Eval Clin Pract 2017;23.
15. Rogers WA, Mintzker Y. Response to bjorn hofmann: Clarifying overdiagnosis without losing conceptual complexity. J Eval Clin Pract 2017;23.
16. Hofmann B. Defining and evaluating overdiagnosis. J Med Ethics 2016:715-6.
17. Carter SM, Degeling C, Doust J, et al. A definition and ethical evaluation of overdiagnosis. J Med Ethics 2016:705-14.
18. Paris J, Bhat V, Thombs B. Is adult attention-deficit hyperactivity disorder being overdiagnosed? Can J Psychiatry 2015;60:324-8.
19. Pathirana T, Clark J, Moynihan R. Mapping the drivers of overdiagnosis to potential solutions. BMJ 2017;358:j3879.
20. Hofmann BM. Too much technology. BMJ 2015;350:h705.
21. Doust J, Glasziou P. Is the problem that everything is a diagnosis? Aust Fam Physician 2013;42:856-9.
22. Winters BS, Solarz M, Jacovides CL, et al. Overdiagnosis of pulmonary embolism: evaluation of a hypoxia algorithm designed to avoid this catastrophic problem. Clin Orthop Relat Res 2012;470:497-502.
23. Suh JM, Cronan JJ, Healey TT. Dots are not clots: the over-diagnosis and over-treatment of PE. Emerg Radiol 2010;17:347-52.
24. Bruchmuller K, Margraf J, Schneider S. Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. J Consult Clin Psychol 2012;80:128-38.
25. Bonati M, Reale L. Reducing overdiagnosis and disease mongering in ADHD in Lombardy. BMJ 2013;347:f7474.
26. Harchut K, Standley C, Dobson A, et al. Over-diagnosis of malaria by microscopy in the kilombero valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests. Malar J 2013;12:159.
27. Mwanziva C, Shekalaghe S, Ndaro A, et al. Overuse of artemisinincombination therapy in mto wa mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J 2008;7:232.
28. Pelzer AE, Colleselli D, Bektic J, et al. Over-diagnosis and underdiagnosis of screen-vs non-screen-detected prostate cancers with in men with prostate-specific antigen levels of 2.0-10.0 ng/mL. BJU Int 2008;101:1223-6.
29. Heijnsdijk EA, de Carvalho TM, Auvinen A, et al. Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data. J Natl Cancer Inst 2015;107:366.
30. Arnsrud Godtman R, Holmberg E, Lilja H, et al. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial. Eur Urol 2015;68:354-60.
31. Beckmann K, Duffy SW, Lynch J, et al. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects. J Med Screen 2015;22:127-35.
32. Seigneurin A, Labarere J, Francois O, et al. Overdiagnosis and overtreatment associated with breast cancer mammography screening: a simulation study with calibration to population-based data. Breast 2016;28:60-6.
33. Gunsoy NB, Garcia-Closas M, Moss SM. Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom. Br J Cancer 2014;110:2412-9.
34. Etzioni R, Gulati R, Mallinger L, et al. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med 2013;158:831-8.
35. Phelps J, Ghaemi SN. The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11. Acta Psychiatr Scand 2012;126:395-401.
36. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord 2007;11:106-13.
37. Garcia-Rio F, Soriano JB, Miravitlles M, et al. Overdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of life. Chest 2011;139:1072-80.
38. Guder G, Brenner S, Angermann CE, et al. "GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohortstudy". Respir Res 2012;13:13.
39. Aaron SD, Vandemheen KL, Boulet LP, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008;179:1121-31.
40. Evans AJ, Pinder SE, Ellis IO, et al. Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screen 2001;8:149-51.
41. Van der Kwast TH, Roobol MJ. Defining the threshold for significant versus insignificant prostate cancer. Nat Rev Urol 2013;10:473-82.
42. Vaccarella S, Dal Maso L, Laversanne M, et al. The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 2015;25:1127-36.
43. Moynihan R, Nickel B, Hersch J, et al. What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians. BMJ Open 2015;5:e007436.
44. Hersch J, Jansen J, Barratt A, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ 2013;346:f158.
45. Moynihan R, Nickel B, Hersch J, et al. Public opinions about overdiagnosis: a national community survey. PLoS One 2015;10:e0125165.
46. van Agt H, Fracheboud J, van der Steen A, et al. Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination. Patient Educ Couns 2012;89:353-9.
47. Wegwarth O, Gigerenzer G. Less is more: Overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med 2013;173:2086-7.
48. Bae JM. Development and application of patient decision aids. Epidemiol Health 2015;37:e2015018.
49. Hersch J, Barratt A, Jansen J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015;385:1642-52.
50. Day M. Drug industry is partly to blame for overdiagnosis of bipolar disorder, researchers claim. BMJ 2008;336:1092-3.
51. Carneiro AV. Screening for coronary artery disease in assymptomatic adults is not recommended, so why is it still done? Rev Port Cardiol 2004;23:1633-8.
52. Hoffman JR, Carpenter CR. Guarding against overtesting, overdiagnosis, and overtreatment of older adults: thinking beyond imaging and injuries to weigh harms and benefits. J Am Geriatr Soc 2017;65:903-5.
53. de Roos MA, van der Vegt B, de Vries J, et al. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol 2007;14:2097-104.
54. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014;384:2027-35.
55. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
56. Andriole GL, Crawford ED, Grubb RL, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104:125-32.
57. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-8.
58. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostatecancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8.
59. Wu D, Pirez A. A limited review of over diagnosis methods and long term effects in breast cancer screening. Oncol Rev 2011;5:143-7.
60. Duffy SW, Lynge E, Jonsson H, et al. Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer 2008;99:1176-8.
61. de Gelder R, Heijnsdijk EA, van Ravesteyn NT, et al. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011;33:111-21.
62. Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009;101:374-83.
63. Puliti D, Miccinesi G, Paci E. Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Prev Med 2011;53:131-3.
64. Davidov O, Zelen M. Overdiagnosis in early detection programs. Biostatistics 2004;5:603-13.
65. Marcus PM, Prorok PC, Miller AB, et al. Conceptualizing overdiagnosis in cancer screening. J Natl Cancer Inst 2015;107:djv014.
66. Patz EF, Pinsky P, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269-74.
67. Schermer TR, Smeele IJ, Thoonen BP, et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J 2008;32:945-52.
68. Sconfienza LM, Mauri G, Muzzupappa C, et al. Relevant incidental findings at abdominal multi-detector contrast-enhanced computed tomography: a collateral screening? World J Radiol 2015;7:350-6.
69. Hall AE, Chowdhury S, Pashayan N, et al. What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer? J Med Ethics 2014;40:163-7.